Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × fasudil × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Cognitive Dysfunction 1 Alzheimer Disease 1

Interventions

Cyclophosphamide 12 Rituximab 9 fludarabine 6 Prednisone 5 Vinorelbine 4 Vincristine 4 Epirubicin 4 zanubrutinib 3 Nivolumab 3 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3 Gemcitabine 3 Drug Therapy 3 pegylated granulocyte colony-stimulating factor 2 fludarabine phosphate 2 Thiotepa 2 Metformin 2 Ifosfamide 2 Granulocyte Colony-Stimulating Factor 2 Etoposide 2 Doxorubicin 2 Cytarabine 2 Bortezomib 2 treosulfan 1 plerixafor 1 pegfilgrastim 1 parsaclisib 1 obinutuzumab 1 nilotinib 1 liposomal doxorubicin 1 ivarmacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06362707 2024-10-22

FEAD

Helse Stavanger HF

Phase 2 Recruiting

Alzheimer Disease, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡